Cargando…

Targeting K-Ras and apoptosis-driven cellular transformation in cancer

Cellular transformation is a major event that helps cells to evade apoptosis, genomic instability checkpoints, and immune surveillance to initiate tumorigenesis and to promote progression by cancer stem cell expansion. However, the key molecular players that govern cellular transformation and ways t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Godwin, Isha, Anto, Nikhil Ponnoor, Bava, Smitha V., Babu, Mani Shankar, Jinesh, Goodwin G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047025/ https://www.ncbi.nlm.nih.gov/pubmed/33854056 http://dx.doi.org/10.1038/s41420-021-00457-5

Ejemplares similares

Molecular genetics and cellular events of K-Ras-driven tumorigenesis
por: Jinesh, G G, et al.
Publicado: (2018)

A Covalent Calmodulin Inhibitor as a Tool to Study Cellular Mechanisms of K-Ras-Driven Stemness
por: Okutachi, Sunday, et al.
Publicado: (2021)

K-Ras Binds Calmodulin-Related Centrin1 with Potential Implications for K-Ras Driven Cancer Cell Stemness
por: Manoharan, Ganesh babu, et al.
Publicado: (2023)

Corrigendum: Cucurbitacin B, purified and characterized from the rhizome of Corallocarpus epigaeus exhibits anti-melanoma potential
por: Aiswarya, Sreekumar Usha Devi, et al.
Publicado: (2022)

Cucurbitacin B, Purified and Characterized From the Rhizome of Corallocarpus epigaeus Exhibits Anti-Melanoma Potential
por: Aiswarya, Sreekumar Usha Devi, et al.
Publicado: (2022)

Sequential gemcitabine and tamoxifen treatment enhances apoptosis and blocks transformation in bladder cancer cells
por: TAKEUCHI, HISASHI, et al.
Publicado: (2015)

ATOH8 binds SMAD3 to induce cellular senescence and prevent Ras-driven malignant transformation
por: Liu, Ximeng, et al.
Publicado: (2023)

MYC and RAS are unable to cooperate in overcoming cellular senescence and apoptosis in normal human fibroblasts
por: Zhang, Fan, et al.
Publicado: (2018)

Targeting Thymidylate Synthase Enhances the Chemosensitivity of Triple-Negative Breast Cancer Towards 5-FU-Based Combinatorial Therapy
por: Haritha, Nair Hariprasad, et al.
Publicado: (2021)

Classical epithelial-mesenchymal transition (EMT) and alternative cell death process-driven blebbishield metastatic-witch (BMW) pathways to cancer metastasis
por: Jinesh, Goodwin G., et al.
Publicado: (2022)

[6]-Gingerol Induces Caspase-Dependent Apoptosis and Prevents PMA-Induced Proliferation in Colon Cancer Cells by Inhibiting MAPK/AP-1 Signaling
por: Radhakrishnan, EK, et al.
Publicado: (2014)

The role of AMPK in cancer metabolism and its impact on the immunomodulation of the tumor microenvironment
por: Keerthana, Chenicheri Kizhakkeveettil, et al.
Publicado: (2023)

PGA(1)-induced apoptosis involves specific activation of H-Ras and N-Ras in cellular endomembranes
por: Anta, B, et al.
Publicado: (2016)

The ARF tumor suppressor controls Drosha translation to prevent Ras-driven transformation
por: Kuchenreuther, Michael J., et al.
Publicado: (2013)

Role of autophagy in K-RAS- and B-RAF-driven lung cancers
por: White, Eileen
Publicado: (2014)

Involvement of Autophagy in Oncogenic K-Ras-induced Malignant Cell Transformation
por: Kim, Min-Jung, et al.
Publicado: (2011)

Activation of K-RAS by co-mutation of codons 19 and 20 is transforming
por: Naguib, Adam, et al.
Publicado: (2011)

The Crossroads between RAS and RHO Signaling Pathways in Cellular Transformation, Motility and Contraction
por: Soriano, Olga, et al.
Publicado: (2021)

Regulation of H-Ras-driven MAPK signaling, transformation and tumorigenesis, but not PI3K signaling and tumor progression, by plasma membrane microdomains
por: Michael, J V, et al.
Publicado: (2016)

Recent Developments in Targeting RAS Downstream Effectors for RAS-Driven Cancer Therapy
por: Tatli, Ozge, et al.
Publicado: (2021)

Targeting the PI3K/Akt pathway in murine MDS/MPN driven by hyperactive Ras
por: Akutagawa, Jon, et al.
Publicado: (2016)

The Role of Wild-Type RAS in Oncogenic RAS Transformation
por: Sheffels, Erin, et al.
Publicado: (2021)

6,6′-Dihydroxythiobinupharidine (DTBN) Purified from Nuphar lutea Leaves Is an Inhibitor of Protein Kinase C Catalytic Activity
por: Waidha, Kamran, et al.
Publicado: (2021)

Mutant p53s and chromosome 19 microRNA cluster overexpression regulate cancer testis antigen expression and cellular transformation in hepatocellular carcinoma
por: Jinesh, Goodwin G., et al.
Publicado: (2021)

Efficacy of MEK inhibition in a K-Ras-driven cholangiocarcinoma preclinical model
por: Dong, Mingjie, et al.
Publicado: (2018)

JAK–STAT inhibition impairs K‐RAS‐driven lung adenocarcinoma progression
por: Mohrherr, Julian, et al.
Publicado: (2019)

Pre‐clinical evidences for the efficacy of tryptanthrin as a potent suppressor of skin cancer
por: Shankar G., Mohan, et al.
Publicado: (2019)

Multilayering and loss of apical polarity in MDCK cells transformed with viral K-ras
Publicado: (1991)

Biglycan as a potential regulator of tumorgenicity and immunogenicity in K-RAS-transformed cells
por: Subbarayan, Karthikeyan, et al.
Publicado: (2022)

Novel PKC-ζ to p47(phox) interaction is necessary for transformation from blebbishields
por: Jinesh, Goodwin G., et al.
Publicado: (2016)

How do K-RAS-activated cells evade cellular defense mechanisms?
por: Lee, Y-S, et al.
Publicado: (2016)

Anti-helminthic niclosamide inhibits Ras-driven oncogenic transformation via activation of GSK-3
por: Ahn, Sung Yong, et al.
Publicado: (2017)

Selective killing of K-ras–transformed pancreatic cancer cells by targeting NAD(P)H oxidase
por: Wang, Peng, et al.
Publicado: (2015)

Killer K-Ras
por: Powell, Kendall
Publicado: (2006)

K-RAS Is…Complicated
por: Clark, Geoffrey J.
Publicado: (2023)

Glutamine Deprivation Induces Abortive S-Phase Rescued by Deoxyribonucleotides in K-Ras Transformed Fibroblasts
por: Gaglio, Daniela, et al.
Publicado: (2009)

Neoplastic Transformation of Rat Colon Epithelial Cells by Expression of Activated Human K‐ras
por: Sugiyama, Kenji, et al.
Publicado: (1998)

Sensitization of Human Pancreatic Cancer Cells Harboring Mutated K-ras to Apoptosis
por: Shen, Ling, et al.
Publicado: (2012)

ST2 gene products critically contribute to cellular transformation caused by an oncogenic Ras mutant
por: Tago, Kenji, et al.
Publicado: (2017)

Insights into an Immunotherapeutic Approach to Combat Multidrug Resistance in Hepatocellular Carcinoma
por: Devan, Aswathy R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9p81tig0h46fs904fephubjpd8